Navigation Links
Collaboration needed for strengthening medical research in Europe

Public spending on medical research in Europe should be doubled over the next ten years to ensure health and welfare for Europes citizens and to nurture a thriving European medical research industry. There should be greater collaboration between European institutions in medical research and improved career paths for medical scientists.

These are some of the main recommendations of the European Medical Research Councils (EMRC) White Paper, Present Status and Future Strategy for Medical Research in Europe which was debated at a meeting on 30 January 2008 in Frankfurt (Germany) with the participation of the Heads of Medical Research Councils in Europe, Editors of Medical Journals, Presidents of Medical Learned Societies and Deans of Medical Faculties in Europe.

The audience acclaimed the White paper and made the following recommendations:

  • Increased funding must be by sustainable growth,
  • Collaboration on big programmes is essential,
  • Research areas should be determined by health priorities and not only science topics,
  • Collaboration on an improvement of peer review of grants is essential - and peer reviewers should be acknowledged and rewarded,
  • MD/PhD programmes are important and should be of high quality,
  • the best researchers - like the Nobel Laureates at The Lindau meeting - to participate in teaching,
  • Novel technologies and research infrastructures are important as well as incentive in terms of decent salaries to attract and retain young researchers

To make the White Paper recommendations come true European and global collaboration is needed.

The White Paper is the result of a comprehensive analysis of the current state of medical research within Europe together with an assessment of the new challenges facing Europes citizens, with changing patterns of disease, environmental issues as global warming, and changing demographic factors with an ageing population. The paper was launched at a meeting between Janez Potonik, EU Commissioner for Science and Research, and Professor Liselotte Hjgaard, Chair of the European Medical Research Councils in Brussels on 6 December 2007.

The White Paper key recommendations include:

  • Implementation of best practice for funding and performing medical research with distribution of funding in competition based on excellence and evaluated by peer review
  • Strengthened collaboration and coordination of medical research in Europe through the EMRC and its membership organisations, via the European Commission, the European Research Council and the learned medical societies
  • Revision of EC directives related to medical research
  • Implementation of equal opportunities for all researchers
  • A doubling of public funding of medical research in Europe within the next ten years to a minimum of 0.25% of gross domestic product (GDP)

Contact: Liselotte Hjgaard
European Science Foundation

Related medicine news :

1. Linguamatics and 81qd Sign Multi-Year Collaboration in Knowledge Discovery for Product Life Cycle Management
2. Wiley-Blackwell and the Cochrane Collaboration extend publishing partnership
3. IDM Pharma Announces Termination of UVIDEM Development Collaboration and Expected Restructuring in Connection With Evaluation of Strategic Alternatives
4. International research collaboration narrows focus on genetic cause of Kawasaki disease
5. BioSeek Initiates Systems Biology Compound Evaluation Collaboration with UCB
6. Pharmacopeia and GlaxoSmithKline Collaboration Identifies Two Additional Lead Compounds
7. Xenome Enters Into Joint Research Collaboration to Discover Novel Peptide Therapeutics with Amylin Pharmaceuticals
8. Safeway Inc. and the Prostate Cancer Foundation to Fund Landmark Prostate Cancer Research Collaboration
9. Beactica Announces Drug Discovery Collaboration With Arrow Therapeutics
10. 3M, Gen-Probe to Discontinue Molecular Food Testing Collaboration
11. Warner Chilcott and NexMed Sign U.S. Collaboration for Topical Alprostadil Treatment for Erectile Dysfunction
Post Your Comments:
(Date:12/1/2015)... ... December 01, 2015 , ... ... and hematology continuing medical education (CME), today announced that the first annual School ... New York. , “The prevention, detection and treatment of gastrointestinal cancers are undergoing ...
(Date:12/1/2015)... , ... December 01, 2015 , ... Growth in medical ... due to decreases in utilization of hospital and nonhospital care, according to a recent ... Medical Benchmarks for Louisiana, 16th Edition , found medical payments per claim with more ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... images have been lifted as IMAGE Information Systems launches MED-TAB™ -- the world’s ... America Annual Meeting from November 29 to December 4, 2015. , MED-TAB ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... Inc. (“Visage”), a wholly owned subsidiary of Pro Medicus Ltd. (ASX: PME), has ... the Radiological Society of North America (RSNA) 2015 annual meeting through December 3 ...
(Date:12/1/2015)... (PRWEB) , ... December 01, 2015 , ... ... clinical solutions for the care management and population health arenas, is pleased to ... clinical and cost containment services, has successfully implemented the ACUITY Complete Care™ Management ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... , Dec. 2, 2015  A combination of detailed ... the first time in the surgical planning for separation of ... annual meeting of the Radiological Society of North ... --> Conjoined twins, or twins whose bodies are connected, ... rates are low and separating them through surgery is extremely ...
(Date:12/1/2015)... , Dec. 1, 2015  A large study ... drug tamoxifen while taking an antidepressant found no increased ... today in The Journal of the National Cancer Institute. ... Tamoxifen is a commonly prescribed generic drug taken by ... developing a recurrence. Tamoxifen is recommended for five years, ...
(Date:12/1/2015)... Wash. and VANCOUVER , ... Committee (DMC) meeting, OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI ... is continuing based on the pre-planned interim futility analysis ... review, no new safety issues were identified by the ... all analyses and final results are expected in the ...
Breaking Medicine Technology: